Treatment of high-output enteric fistula

For use with UpToDate content on management of ECF and EAF in adult patients.

EAF: enteroatmospheric fistula; ECF: enterocutaneous fistula; GLP-2: glucagonlike peptide-2; IV: intravenous; PPI: proton pump inhibitor.

* Because supratherapeutic doses can prolong QTc and cause cardiac arrhythmias, it is advisable to obtain an electrocardiogram when increasing the dose to >16 mg/day.